Products


Transplant

ENVARSUS XR (tacrolimus extended-release tablets)

Prescribing Information including BOXED WARNING

Medication Guide

Product website

Cardiovascular

FENOGLIDE

In August 2007, the FDA approved Fenoglide for the treatment of dyslipidemia in the United States. Veloxis has out-licensed the commercial rights of Fenoglide for the United States, Canada and Mexico.

The commercial rights are held by Valeant Pharmaceuticals International, Inc.